Genetically diverse mouse models of SARS-CoV-2 infection reproduce clinical variation in type I interferon and cytokine responses in COVID-19

Shelly J. Robertson(National Institute of Allergy and Infectious Diseases), Sonja M. Best(National Institutes of Health)
Nature Communications
July 25, 2023
10.1038/s41467-023-40076-5
Cited by 24

Related Papers

TRIM5α restricts flavivirus replication by targeting the viral protease for proteasomal degradation
|bioRxiv (Cold Spring Harbor Laboratory)|2019|2
Mitophagy antagonism by Zika virus reveals Ajuba as a regulator of PINK1-Parkin signaling, PKR-dependent inflammation, and viral invasion of tissues
|bioRxiv (Cold Spring Harbor Laboratory)|2021|2
AP3B1 Has Type I Interferon-Independent Antiviral Function against SARS-CoV-2
|Viruses|2024|2
Restraint of Powassan virus replication by TRIM5α facilitates viral avoidance of antiviral immunity
|bioRxiv (Cold Spring Harbor Laboratory)|2026|0